This inventor holds 4 USPTO granted patents. Top assignees: Commonwealth Scientific and Industrial Research Organisation, Ludwig Institute for Cancer Research Limited, Walter and Eliza Hall Institute of Medical Research. Active years: 1997-2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- North Balwyn, AU (2008)
- Lilydale, AU (1997 - 2012)
Company Filing History:
3 out of 1,355 
2 out of 530 
1 out of 84 
Years Active: 1997-2012
Title: Neil Moreton McKern: Innovator in Insulin Receptor Research
Introduction
Neil Moreton McKern, hailing from Lilydale, Australia, is a prominent inventor known for his significant contributions to biochemistry and molecular biology. With a total of four patents to his name, McKern's research primarily revolves around the structures and functions of key receptor proteins involved in critical biological processes.
Latest Patents
Among his latest patents is the invention titled "Structure of the Insulin Receptor Ectodomain." This groundbreaking work relates to the crystal structure of the insulin receptor ectodomain and explores the nature of its N-linked glycans. It also outlines methods for utilizing this structural information to screen for and design compounds that interact with or modulate the insulin receptor and insulin-like growth factor receptors. Another notable patent is for the "Truncated EGF Receptor." This invention focuses on truncated EGF receptor molecules that demonstrate increased binding affinities for ligands such as EGF and TGF1. Additionally, it includes methods for screening EGF receptor ligands and treatment methods employing these innovative molecules.
Career Highlights
McKern has worked with esteemed organizations, including the Commonwealth Scientific and Industrial Research Organisation (CSIRO) and the Ludwig Institute for Cancer Research Limited. His work in these prominent research institutions has played a crucial role in advancing the understanding of receptor biology.
Collaborations
Throughout his career, Neil Moreton McKern has collaborated with distinguished colleagues such as Colin Wesley Ward and Robert Nicholas Jorissen. These collaborations reflect the synergy among scientists striving to push the boundaries of scientific knowledge and innovation in their field.
Conclusion
Neil Moreton McKern continues to be a trailblazer in the area of receptor research. His innovative patents and collaborations highlight his commitment to understanding the molecular underpinnings of essential biological processes. As his work takes shape within the scientific community, it paves the way for potential breakthroughs in medical treatments and biotechnological advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile